CM Lilly, TR Bai, SA Shore, AE Hall and JM Drazen
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Tracheal and lung parenchymal SP-LI (substance P-like immunoreactivity) and VIP-LI (vasoactive intestinal peptide-like immunoreactivity) content was measured in HPLC-purified tissue extracts from patients with and without asthma. We detected significantly less SP-LI in tracheal tissue from asthmatic than from nonasthmatic patients, whereas parenchymal SP-LI content was not significantly different between these groups. This finding does not support the concept that asthmatic lungs contain excessive amounts of SP. Indeed, lower SP-LI content of tracheal tissues from asthmatic patients may reflect augmented SP release followed by degradation. We detected greater quantities of VIP- LI in tracheal than in parenchymal tissue in both groups, but did not detect significant differences in VIP-LI content in tracheal or parenchymal tissues from asthmatic and nonasthmatic patients. These findings indicate that asthmatic and nonasthmatic lungs contain similar levels of VIP.

This article has been cited by other articles:

				G. F. JOOS, K. O. DE SWERT, V. SCHELFHOUT, and R. A. PAUWELS The Role of Neural Inflammation in Asthma and Chronic Obstructive Pulmonary Disease Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 218 - 230. [Abstract] [Full Text] [PDF]

				P A Beckett and P H Howarth Pharmacotherapy and airway remodelling in asthma? Thorax, February 1, 2003; 58(2): 163 - 174. [Abstract] [Full Text] [PDF]

				T. Saaresranta and O. Polo Hormones and Breathing Chest, December 1, 2002; 122(6): 2165 - 2182. [Abstract] [Full Text] [PDF]

				P. J. BARNES Endogenous Inhibitory Mechanisms in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181. [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				P. CHANEZ, D. SPRINGALL, A. M. VIGNOLA, A. MORADOGHI-HATTVANI, J. M. POLAK, P. GODARD, and J. BOUSQUET Bronchial Mucosal Immunoreactivity of Sensory Neuropeptides in Severe Airway Diseases Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 985 - 990. [Abstract] [Full Text] [PDF]

				T. Takebayashi, J. Abraham, G. G. K. Murthy, C. Lilly, I. Rodger, and S. A. Shore Role of tachykinins in airway responses to ozone in rats J Appl Physiol, August 1, 1998; 85(2): 442 - 450. [Abstract] [Full Text] [PDF]

				C. E. MAPP, R. E. LUCCHINI, D. MIOTTO, P. CHITANO, L. JOVINE, M. SAETTA, P. MAESTRELLI, D. R. SPRINGALL, J. POLAK, and L. M. FABBRI Immunization and Challenge with Toluene Diisocyanate Decrease Tachykinin and Calcitonin Gene-Related Peptide Immunoreactivity in Guinea Pig Central Airways Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 263 - 269. [Abstract] [Full Text] [PDF]

				J. G Ayres, J. F Miles, and P. J Barnes Brittle asthma Thorax, April 1, 1998; 53(4): 315 - 321. [Full Text]

				R. Lucchini, F Facchini, G Turato, M Saetta, G Caramori, A Ciaccia, P Maestrelli, D. Springall, J. Polak, L Fabbri, et al. Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1963 - 1968. [Abstract] [Full Text]

				A. D. KRANEVELD, F. P. NIJKAMP, and A. J. M. VAN OOSTERHOUT Role for Neurokinin-2 Receptor in Interleukin-5-induced Airway Hyperresponsiveness but not Eosinophilia in Guinea Pigs Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 367 - 374. [Abstract] [Full Text]